FDA approvals drop 24% in H1 2025; GSK’s UTI med, Vertex’s non-opioid painkiller lead pack of first-in-class meds

Data Compilation
#PharmaFlow

Pipeline Prospector August 2025: Novo’s Wegovy approved for MASH, Tonix Pharma’s fibromyalgia drug okayed

Stock Recap
#PipelineProspector

VOSOL HC-1

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

86 API Suppliers, 29 USDMF, 14 CEP/COS, 6 JDMF, 12 EU WC, 10 KDMF, 40 NDC API, 1 VMF, 32 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

112 Drugs in Development

112 Drugs in Development

FINISHED DOSAGE FORMULATIONS

389 FDF Dossiers, 234 FDA Orange Book, 83 Europe, 14 Canada, 8 Australia, 27 South Africa, 23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1%, CREAM;TOPICAL - 5%;1%, OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 1%, LOTION;TOPICAL - 2%, TABLET;ORAL - 10MG, TABLET;ORAL - 20MG, TABLET;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Rochem International Inc, 8 SPI Pharma, 17 DKSH, 1 Pharm-RX Chemical, 6 Gangwal Healthcare, 24 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 4 Pfanstiehl, 23 Kirsch Pharma, 22 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 42 BASF, 3 BioSpectra, 4 CD Formulation, 1 Clariant, 15 Corel Pharma Chem, 7 DFE Pharma, 3 Esteem Industries, 6 Finar, 16 Gangwal Chemicals, 2 Hayashibara, 2 Ideal Cures, 4 Ingredion Pharma Solutions, 19 Kerry, 3 Keval Exports, 9 Lubrizol Life Science Health, 17 Microlex e.U, 3 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 33 Roquette, 21 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 5 Silverline Chemicals, 1 Symrise, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

92 Topical, 64 Thickeners and Stabilizers, 60 Solubilizers, 58 Parenteral, 57 Fillers, Diluents & Binders, 36 Direct Compression, 33 Granulation, 33 Emulsifying Agents, 28 Lubricants & Glidants, 27 Coating Systems & Additives, 27 Disintegrants & Superdisintegrants, 23 Surfactant & Foaming Agents, 23 Controlled & Modified Release, 20 Film Formers & Plasticizers, 18 Taste Masking, 14 Co-Processed Excipients, 12 Chewable & Orodispersible Aids, 10 Rheology Modifiers, 6 API Stability Enhancers, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 49 News #PharmaBuzz

GLOBAL SALES INFORMATION

38 US Medicaid Prescriptions, 91 Regulatory FDF Prices, 1 Annual Reports

MARKET PLACE

35 APIs, 17 FDF Dossiers

PATENTS & EXCLUSIVITIES

14 US Patents, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 3 JP, 27 Others

ANALYTICAL

2 BioAnalytical Methods, 4 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
06/09/2025	Symbiotec Pharmalab	India	M/s. Symbiotec Pharmalab Private Limited	WC-0162	Hydrocortisone BP/Ph. Eur./USP	2025-07-25	2028-07-02	Plot No. 5,6,7 & 8, Phase Il, Pharma Zone, SEZ, District - Dhar, Pithampur, Madhya Pradesh, 454774, India
06/09/2025	Symbiotec Pharmalab	India	M/s. Symbiotec Pharmalab Private Limited	WC-0162	Hydrocortisone Hemisuccinate BP/USP	2025-07-25	2028-07-02	Plot No. 5,6,7 & 8, Phase Il, Pharma Zone, SEZ, District - Dhar, Pithampur, Madhya Pradesh, 454774, India

VOSOL HC-1

VOSOL HC-1

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

86 API Suppliers

29 USDMF

14 CEP/COS

6 JDMF

12 EU WC

10 KDMF

40 NDC API

1 VMF

32 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

112 Drugs in Development

FINISHED DOSAGE FORMULATIONS

389 FDF Dossiers

234 FDA Orange Book

83 Europe

14 Canada

8 Australia

27 South Africa

23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1%

CREAM;TOPICAL - 5%;1%

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 1%

LOTION;TOPICAL - 2%

TABLET;ORAL - 10MG

TABLET;ORAL - 20MG

TABLET;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

4 Rochem International Inc

8 SPI Pharma

17 DKSH

1 Pharm-RX Chemical

6 Gangwal Healthcare

24 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

4 Pfanstiehl

23 Kirsch Pharma

22 Actylis

1 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

42 BASF

3 BioSpectra

4 CD Formulation

1 Clariant

15 Corel Pharma Chem

7 DFE Pharma

3 Esteem Industries

6 Finar

16 Gangwal Chemicals

2 Hayashibara

2 Ideal Cures

4 Ingredion Pharma Solutions

19 Kerry

3 Keval Exports

9 Lubrizol Life Science Health

17 Microlex e.U

3 Nanjing Bold Chemical

2 Nippon Fine Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

1 Novo Excipients

2 Pharmatrans-Sanaq

7 Pluviaendo

4 Prachin Chemical

33 Roquette

21 Seppic

2 Shandong Focus Biotechnology Co., Ltd

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons